News
AbbVie has become the latest pharma group to make a big capital investment announcement in the US and court favour with the ...
Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback